$INO 50% upside potentialNASDAQ:INO had a streak of green weeks recently and currently is trading above a significant resistance at $11.96
- MACD weekly just turned positive
- Vortex index is positive
Next report date
Report period
Q1 2024
EPS estimate
−0.92EUR
Revenue estimate
139.02 KEUR
−5.54EUR
−122.42 MEUR
753.81 KEUR
25.71 M
About Inovio Pharmaceuticals, Inc.
Sector
CEO
Jacqueline E. Shea
Headquarters
Plymouth Meeting
Website
Employees (FY)
122
Founded
1983
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
INO 1D 2 Month Larger TF shows continuation. Time/Space corrective until wave (B). Breakout of falling wedge finished. Retracement and continuation.
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases a
INO Bullish Deep CrabINO has completed a bottom formation IMO. I believe the bottom has come in a harmonic deep crab formation. I've highlighted the accumulation zone. This is high risk but also has the potential of being a 5 to 100x bagger. Good Luck!
💊 INO SELL THE BREAK 📉INO has broken out of a larger degree correction and continues to make smaller degree flags in the bearish direction.
Stick to your trading rules!
Inovio timeCovid is here to stay!
Data from the WHO will be good. Time to buy and hold. Let the shorts
INO 1W 168% from $1.92Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was found
inovio will hit rock bottom and will make you rich, unless, Unless the company ends bad . .
i wouldnt know as i only read charts and follow trend .
i say that ino will hit the 47-50c mark , but hey , take a look at its highest high : $180
ok im not that positive or healthy to live another 30 years or so ,... but it might be a stock worth following .
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GBM is 11.22 EUR — it has increased by 0.18% in the past 24 hours. Watch INOVIO PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange INOVIO PHARMACEUTICALS INC stocks are traded under the ticker GBM.
INOVIO PHARMACEUTICALS INC is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
GBM stock is 2.35% volatile and has beta coefficient of 1.63. Track INOVIO PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is INOVIO PHARMACEUTICALS INC there?
GBM earnings for the last quarter are −1.48 EUR per share, whereas the estimation was −1.44 EUR resulting in a −2.63% surprise. The estimated earnings for the next quarter are −1.07 EUR per share. See more details about INOVIO PHARMACEUTICALS INC earnings.
INOVIO PHARMACEUTICALS INC revenue for the last quarter amounts to 367.47 K EUR despite the estimated figure of 110.37 K EUR. In the next quarter revenue is expected to reach 326.16 K EUR.
Yes, you can track INOVIO PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
GBM stock has risen by 20.13% compared to the previous week, the month change is a 2.26% fall, over the last year INOVIO PHARMACEUTICALS INC has showed a 151.01% increase.
GBM net income for the last quarter is −22.65 M EUR, while the quarter before that showed −32.10 M EUR of net income which accounts for 29.42% change. Track more INOVIO PHARMACEUTICALS INC financial stats to get the full picture.
Today INOVIO PHARMACEUTICALS INC has the market capitalization of 292.33 M, it has decreased by 0.91% over the last week.
No, GBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INOVIO PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
As of May 4, 2024, the company has 122.00 employees. See our rating of the largest employees — is INOVIO PHARMACEUTICALS INC on this list?
We've gathered analysts' opinions on INOVIO PHARMACEUTICALS INC future price: according to them, GBM price has a max estimate of 36.54 EUR and a min estimate of 7.31 EUR. Watch GBM chart and read a more detailed INOVIO PHARMACEUTICALS INC stock forecast: see what analysts think of INOVIO PHARMACEUTICALS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INOVIO PHARMACEUTICALS INC EBITDA is −117.71 M EUR, and current EBITDA margin is −15.83 K%. See more stats in INOVIO PHARMACEUTICALS INC financial statements.